; references in subtitle. Part 1—OTC Drug Review Sec. 371. Regulation of certain nonprescription drugs that are marketed without an approved drug application. Sec. 372. Misbranding. Sec. 373. Drugs excluded from the over-the-counter drug review. Sec. 374. Treatment of Sunscreen Innovation Act. Sec. 375. Annual update to Congress on appropriate pediatric indication for certain OTC cough and cold drugs. Sec. 376. Technical corrections. Part 2—User Fees Sec. 381. Short title